More

    Good news Peter Thiel and Count Dracula, you can buy blood again



    %%

    Gimme dat sweet, sweet young plasma.

    Image: Ozge Elif Kizil/Anadolu Agency/Getty Images

    By Rachel Kraus

    Scientific evidence and federal approval be damned: young blood is back on the menu.

    Ambrosia, the company that sold plasma transfusions from donors aged 16-25 with the promise of youthful health benefits, shuttered its doors in August after the FDA issued a warning.

    Now, according to a report published Friday by Medium’s OneZero, Ambrosia is back in business.

    “Our patients really want the treatment,” Jesse Karamazin, Ambrosia’s founder, told One Zero.

    Ambrosia charges $8,000 for a one liter transfusion of plasma from “young blood,” which it claims can reduce the effects of aging. There is no scientific evidence to back up this claim, which is why the FDA “caution[ed] consumers against receiving young donor plasma infusions that are promoted as unproven treatment for varying conditions.”

    This type of plasma does have an approved on-label use: it helps prevent blood clotting in older patients. However, the off-label use is not approved by the FDA, and it stated in February that young plasma transfusions for non-approved reasons should only be conducted as part of scientific studies (also known as Investigational New Drug trials, or INDs). 

    In August, this was apparently enough to discourage Karamazin. He wrote a letter to people and publications who contacted the website (including Mashable) notifying them that Ambrosia would be no more.

    “In February, the FDA announced that off-label young plasma treatments should be performed only under IND. As a result, Ambrosia, LLC was dissolved. I am sorry that I wasn’t able to find a way for this company to continue its innovative treatments.”

    However, he did open a new blood transfusion business called Ivy Plasma. The decision to shut down your business due to government warnings, only to open a nearly identical business with a different name, is truly wild. 

    Now, it’s not clear what changed, other than Karamazin presumably deciding that he just didn’t care what the FDA had to say.

    Karamazin also has no plans to go through official channels to validate his plasma business.

    “This treatment is available now,” he told One Zero. “Trials are very expensive, and they take a really long time.”

    Yep, that checks out. Peter Thiel must be thrilled.

    %%

    - Advertisement -

    RELATED ARTICLES

    Recent Articles

    Gloucester couple both diagnosed with lung cancer 5 weeks apart

    GLOUCESTER, Va. (WAVY) — A Gloucester couple is in the fight of their lives, together. During Lung Cancer Awareness Month, they have a story to share and a reminder for others. Lisa and Seth Doyle have known each other since they were 14 years old, and have been together since 18. Together, they share four…

    When Mental Illness Is Severe

    Nov. 18, 2019, 5:00 a.m. ETThere‌ are‌ ‌some‌ ‌crimes‌ ‌that‌ ‌are‌ almost‌ ‌impossible‌ ‌to‌ ‌forget. ‌ ‌For‌ me, ‌they‌ ‌include‌ ‌the‌ ‌death‌ ‌in‌ ‌1999‌ ‌of‌ ‌Kendra‌ ‌Webdale, ‌an‌ ‌aspiring‌ ‌young‌ ‌journalist‌ ‌who‌ ‌was‌ ‌pushed‌ ‌in‌ ‌front‌ ‌of‌ ‌a‌ ‌New‌ ‌York‌ ‌subway‌ ‌train‌ ‌by‌ ‌a‌ ‌29-year-old‌ ‌man‌ ‌with‌ ‌schizophrenia‌ ‌who‌ ‌had‌ ‌stopped‌ ‌taking‌ ‌his‌ ‌medication. ‌That‌…

    Heart patients may not need surgery, study shows

    Heart catheterization (illustrative)iStock A federally-funded study of 5,179 participants in 37 countries showed that heart attack patients may not need surgery after all. The study, called Ischemia, examined the use of traditional preventive measures in patients with heart disease who are at serious risk of heart attack. Ischemia was conducted by researchers at the Stanford…

    Urinary Incontinence Is Common, Often Treatable—but Hard to Discuss

    One-third of Americans over 40 suffer from it, but many people wait years to seek care, if they seek it at all By Laura Landro Laura Landro The Wall Street Journal Biography Updated Nov. 17, 2019 10:03 pm ET If the many health issues that come with aging, one of the most vexing is also…

    Amazon Offered PlayStation Plus 12-Month Memberships for Only $25

    When it comes to deals on 1-Year PlayStation Plus memberships, we're used to seeing deals around $40 pop up at several points during the year - most notably during Black Friday / Cyber Monday. However, the deal that Amazon ran in the wee hours of the morning today, November 18th, was the best that we've…